GUARDIAN PHARMACY OF INDIANAPOLIS NUCLEAR, LLC

Guardian Pharmacy of Indianapolis Nuclear, LLC specializes in the manufacturing of radiopharmaceuticals for nuclear medicine applications, with deep expertise in the preparation, quality control, and secure distribution of radioactive pharmaceutical agents used in diagnostic imaging and targeted therapies. The company operates under stringent cGMP standards to produce isotopic compounds such as technetium-99m, fluorodeoxyglucose, and other short-lived radiotracers, ensuring compliance with FDA and NRC regulations. Their technical capabilities include automated synthesis modules, radiation shielding design, cold kit formulation, and just-in-time logistics for time-sensitive isotopes, enabling reliable supply to clinical nuclear medicine departments. Differentiators include precision dosing protocols, radiolabeling validation, and adherence to USP <825> for radiopharmaceutical compounding. The contractor maintains a consistent, long-term relationship with the Department of Veterans Affairs, providing mission-critical radiopharmaceuticals to VA medical centers nationwide. Their work supports nuclear cardiology, oncology imaging, and neurology diagnostics within the VA’s integrated healthcare network, with contracts structured for sustained, multi-year delivery to ensure uninterrupted patient care. Operating under NAICS 325412, the company is positioned as a specialized manufacturer in the nuclear pharmacy sector, serving the unique demands of medical isotopes that require rapid production, cold chain integrity, and regulatory compliance. Their market focus is narrow but critical, filling a niche where timely access to radiopharmaceuticals directly impacts diagnostic accuracy and treatment outcomes. As a privately held entity with no disclosed federal certifications, Guardian Pharmacy of Indianapolis Nuclear, LLC is geographically anchored in Indianapolis, Indiana, serving federal healthcare systems from a centralized, licensed manufacturing facility. Their operational model reflects a high-reliability supplier model tailored to the precision and regulatory rigor of government-funded nuclear medicine programs.